Polymers with pH-dependent solubility: Possibility of use in the formulation of gastroresistant and controlled-release matrix tablets

Drug Development and Industrial Pharmacy

Volumn 26, Issue 8, 2000, Pages 837-845

  Palmieri, Giovanni Filippo ^a   Michelini, Simona ^a   Di Martino, Piera ^a   Martelli, Sante ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

Author keywords

CAP; CAT; Controlled release; Eudragit; Gastroresistance

Indexed keywords

CELLACEFATE; CELLULOSE ACETATE TRIMELLITATE; DRUG VEHICLE; EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE PHTHALATE; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG SOLUBILITY; FILM COATING; MATRIX TABLET; PH; TABLET COMPRESSION; TABLET DISINTEGRATION TIME;

ACETAMINOPHEN; ACRYLIC RESINS; ANALGESICS, NON-NARCOTIC; CAPSULES; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; GASTRIC ACID; GELS; HYDROGEN-ION CONCENTRATION; POLYMERS; POLYMETHACRYLIC ACIDS; SOLUBILITY; TABLETS;

EID: 0343953083     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100101307     Document Type: Article

References (28)

1. J. W. McGinity, Aqueous Polymeric Coatings for Pharmaceutical Dosage Form, Marcel Dekker, New York, 1989.
2. H. P. Merkle, J. Pharm. Sci., 1444-1448 (1973).
3. M. Calanchi, Microcapsules in a liquid vehicle, Eur. Pat. Appl. EP 38,979 (November 4, 1981).
4. M. Valenti, Process for the microencapsulation of a medicament, medicament so prepared and pharmaceutical compositions comprising it, Eur. Pat. Appl. EP 212,751 (March 4, 1987).
5. S. R. Ghanta and R. E. Guisinger, Pharmaceutical microcapsules containing non-steroidal anti-inflammatory drugs. Pct. Int. Appl. WO 9,505,166 (February 17, 1995).
6. G. G. Encina, S. P. Sanghvi, and J. G. Nairn, Drug Dev. Ind. Pharm., 18(5), 561-579 (1992).
7. K. R. Kurumaddali, W. R. Ravis, and G. V. Betageri, Drug Dev. Ind. Pharm., 20(17), 2659-2669 (1994).
8. G. Weiß, A. Knoch, A. Laicher, F. Stanislaus, and R. Daniels, Int. J. Pharm., 124(1), 87-96 (1995).
9. D. Torres, G. Garcia-Encina, B. Seijo, and Vila Jato, Int. J. Pharm., 121, 239-243 (1995).
10. Y. Kawashima, T. Niwa, H. Takeuchi, T. Hino, and Y. Itoh, J. Pharm. Sci., 81(2), 135-140 (1992).
11. P. Giunchedi, M. L. Torre, L. Maggi, B. Conti, and U. Conte, Drug Dev. Ind. Pharm., 21(3), 315-330 (1995).
12. M. J. Habib and R. Mesue, Drug Dev. Ind. Pharm., 21(12), 1463-1472 (1995).
13. K. Goracinova, Lj. Klisarova, A. Simov, E. Fredro-Kumbaradzi, and L. Petrusevska-Tozi, Drug Dev. Ind. Pharm., 22(3), 255-262 (1996).
14. D. B. Beten, M. Gelbcke, B. Diallo, and A. J. Moës, Int. J. Pharm., 88, 31-37 (1992).
15. H. O. Ammar and R. M. Khalil, Drug Dev. Ind. Pharm., 23(11), 1043-1054 (1997).
16. M. S. Kislalioglu, M. A. Khan, C. Blount, R. W. Goettsch, and S. Bolton, J. Pharm. Sci., 80, 799 (1991).
17. M. A. Khan, J. Dib, and I. K. Reddy, Drug Dev. Ind. Pharm., 22(2), 135-141 (1996).
18. H. Takeuchi, T. Handa, and Y. Kawashima, Drug Dev. Ind. Pharm., 15(12), 1999-2016 (1989).
19. H. E. Huber, L. B. Dale, and G. L. Christenson, J. Pharm. Sci., 55(9), 974-976 (1966).
20. H. Lapidus and N. G. Lordi, J. Pharm. Sci., 55(8), 840-843 (1966).
21. A. C. Shah, N. J. Britten, L. S. Olanoff, and J. N. Badalamenti, J. Controlled Release, 9, 169-175 (1989).
22. P. Giunchedi, L. Maggi, U. Conte, and C. Caramella, Int. J. Pharm., 77, 177-181 (1991).
23. D. Bidah and J. M. Vergnaud, Int. J. Pharm., 77, 81-87 (1991).
24. A. Gazzaniga, M. E. Sangalli, U. Conte, C. Caramella, P. Colombo, and A. La Manna, Int. J. Pharm., 91, 167-171 (1993).
25. M. E. Sangalli, P. Giunchedi, A. Gazzaniga, and U. Conte, Int. J. Pharm., 91, 151-156 (1993).
26. M. Matsumura, H. Nakagami, T. Yamao, K. Takayama, and T. Nagai, Chem. Pharm. Bull., 42(9), 1902-1908 (1994).
27. P. Colombo, R. Bettini, G. Massimo, P L. Catellani, P. Santi, and N. A. Peppas, J. Pharm. Sci., 84(8), 991-997 (1995).
28. A. Laicher and Th. Profitlich, Drug Dev. Ind. Pharm., 21(17), 1929-1939 (1995).